Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2025 »
Home
Forums
Diabetes Management
Diabetes Medication and Drugs
Tirzepatide
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Oldvatr" data-source="post: 2518784" data-attributes="member: 196898"><p>It is a member of the Glutide family of GPL-1 argonists. Be prepared to be a guinea pig since this drug started stage 3 trials for approval in April of this year, so to complete in 2 months shows they are relying on comparisons with its glutide brothers. They are currently recruiting for a 104 week (2 year) trial for safety. They are also recruitng for the CVE and cadio trials to see if there are any other benefits in respect of this drug.</p><p></p><p>The reports submitted to FDA were only for use as an obesity drug, and only give results of weight loss. they do not seem to have tested it with diabetics yet, and the trial did not measure glucose response. However it is being offered for diabetes users now, so this is a read across that was not tested in the trials.</p><p></p><p>Beware, that other members of this family of drugs has recently been linked to the incidence of thryoid cancer, and we have one forum member confirming this unfortunate side effect.</p></blockquote><p></p>
[QUOTE="Oldvatr, post: 2518784, member: 196898"] It is a member of the Glutide family of GPL-1 argonists. Be prepared to be a guinea pig since this drug started stage 3 trials for approval in April of this year, so to complete in 2 months shows they are relying on comparisons with its glutide brothers. They are currently recruiting for a 104 week (2 year) trial for safety. They are also recruitng for the CVE and cadio trials to see if there are any other benefits in respect of this drug. The reports submitted to FDA were only for use as an obesity drug, and only give results of weight loss. they do not seem to have tested it with diabetics yet, and the trial did not measure glucose response. However it is being offered for diabetes users now, so this is a read across that was not tested in the trials. Beware, that other members of this family of drugs has recently been linked to the incidence of thryoid cancer, and we have one forum member confirming this unfortunate side effect. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Management
Diabetes Medication and Drugs
Tirzepatide
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…